Literature DB >> 23417921

Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia.

Karen D Wright1, Mihaela M Onciu, Elaine Coustan-Smith, Dario Campana, Susana C Raimondi, Hiroto Inaba, Raul Ribeiro, Ching-Hon Pui, John T Sandlund.   

Abstract

Dendritic cell leukemia (DCL) or hematodermic tumor is an uncommon subtype of acute leukemia. In contrast to adult cases, children tend to have a less aggressive course. The diagnosis of DCL should be considered when its characteristic morphologic features are present and leukemic cells co-express CD4 and CD56. Cases of DCL among pediatric patients have been reported to respond to therapeutic regimens for acute lymphoblastic leukemia, but details regarding the specifics of therapy are lacking.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2013        PMID： 23417921      PMCID： PMC4146405          DOI： 10.1002/pbc.24483

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  19 in total

1.  An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.

Authors:  K Anargyrou; G Paterakis; D Boutsis; M Politou; S I Papadhimitriou; M Siakandaris; J Vassiliadis; A Androulakis; J Meletis; J Rombos; A Tassiopoulou; G Vaiopoulos
Journal:  Eur J Haematol       Date:  2003-10       Impact factor: 2.997

2.  Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.

Authors:  Danielle M P Cronin; Tracy I George; Kaaren K Reichard; Uma N Sundram
Journal:  Am J Clin Pathol       Date:  2012-03       Impact factor: 2.493

Review 3.  Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.

Authors:  Antonio Ruggiero; Palma Maurizi; Luigi Maria Larocca; Annalisa Arlotta; Riccardo Riccardi
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

4.  Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.

Authors:  S Kaddu; P Zenahlik; C Beham-Schmid; H Kerl; L Cerroni
Journal:  J Am Acad Dermatol       Date:  1999-06       Impact factor: 11.527

5.  Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome.

Authors:  Jorge G Rossi; Maria S Felice; Andrea R Bernasconi; Alejandra E Ribas; Marta S Gallego; Albina E Somardzic; Elizabeth M Alfaro; Cristina N Alonso
Journal:  Leuk Lymphoma       Date:  2006-04

6.  Clinical and biologic features of CD4(+)CD56(+) malignancies.

Authors:  Jean Feuillard; Marie-Christine Jacob; Françoise Valensi; Marc Maynadié; Rémy Gressin; Laurence Chaperot; Christine Arnoulet; Françoise Brignole-Baudouin; Bernard Drénou; Eliane Duchayne; Annie Falkenrodt; Richard Garand; Emanuelle Homolle; Bernard Husson; Emilienne Kuhlein; Geneviève Le Calvez; Danielle Sainty; Marie-France Sotto; Franck Trimoreau; Marie-Christine Béné
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

Review 7.  Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.

Authors:  Tony Petrella; Martine Bagot; Rein Willemze; Marie Beylot-Barry; Béatrice Vergier; Michèle Delaunay; Chris J L M Meijer; Philippe Courville; Pascal Joly; Florent Grange; Anne De Muret; Laurent Machet; Anne Dompmartin; Jacques Bosq; Anne Durlach; Philippe Bernard; Sophie Dalac; Pierre Dechelotte; Michel D'Incan; Janine Wechsler; Michael A Teitell
Journal:  Am J Clin Pathol       Date:  2005-05       Impact factor: 2.493

8.  Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity.

Authors:  Roberto P Falcão; Aglair B Garcia; Maria G Marques; Belinda P Simões; Benedito A Fonseca; Miriam L Rodrigues; Norma T Foss
Journal:  Leuk Res       Date:  2002-09       Impact factor: 3.156

Review 9.  Leukemia cutis.

Authors:  K V Ratnam; C J Khor; W P Su
Journal:  Dermatol Clin       Date:  1994-04       Impact factor: 3.478

Review 10.  What is CD4+CD56+ malignancy and how should it be treated?

Authors:  P Reimer; T Rüdiger; D Kraemer; V Kunzmann; F Weissinger; A Zettl; H Konrad Müller-Hermelink; M Wilhelm
Journal:  Bone Marrow Transplant       Date:  2003-10       Impact factor: 5.483
View more
  1 in total

1.  First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases.

Authors:  Weili Sun; Huaying Liu; Young Kim; Nicole Karras; Anna Pawlowska; Debbie Toomey; Wade Kyono; Paul Gaynon; Joseph Rosenthal; Anthony Stein
Journal:  J Hematol Oncol       Date:  2018-05-02       Impact factor: 17.388
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.